Literature DB >> 17293084

The course of schizophrenia: progressive deterioration, amelioration or both?

Jonathan Rabinowitz1, Stephen Z Levine, Rachel Haim, Heinz Häfner.   

Abstract

BACKGROUND: Schizophrenia may follow a course of amelioration, deterioration or stability. It is possible that deterioration at the aggregate level may be due to a sub-group of patients with a tendency to deteriorate. AIMS: To examine the course of schizophrenia in a national population-based cohort.
METHODS: All first admissions for schizophrenia in Israel 1978-1986 were followed for readmissions in the Israeli psychiatric hospitalization registry for 10 years (n=6865). Readmission rates were examined using cluster analysis. This was followed by an examination of changes in readmission patterns.
RESULTS: Cluster analysis identified a small cluster of patients who spent more days in the hospital over time and two clusters that improved. A priori classification of the patients into deteriorating, improving and stable (based on days hospitalized per year) revealed that approximately 75% of patients improved over time.
CONCLUSIONS: Over time a majority of patients appear to improve and a minority appear to deteriorate.

Entities:  

Mesh:

Year:  2007        PMID: 17293084     DOI: 10.1016/j.schres.2006.12.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Trajectories and antecedents of treatment response over time in early-episode psychosis.

Authors:  Stephen Z Levine; J Rabinowitz
Journal:  Schizophr Bull       Date:  2008-10-09       Impact factor: 9.306

2.  Elaboration on the association between immigration and schizophrenia: a population-based national study disaggregating annual trends, country of origin and sex over 15 years.

Authors:  Nomi Werbeloff; Stephen Z Levine; Jonathan Rabinowitz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-01       Impact factor: 4.328

Review 3.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

4.  Psychopharmacology of schizophrenia: The Future Looks Bleak.

Authors:  Chittaranjan Andrade; Rajiv Radhakrishnan; Praveen P Fernandes
Journal:  Mens Sana Monogr       Date:  2012-01

5.  Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study.

Authors:  Gebra B Cuyún Carter; Denái R Milton; Haya Ascher-Svanum; Douglas E Faries
Journal:  BMC Psychiatry       Date:  2011-08-26       Impact factor: 3.630

6.  Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.

Authors:  Edimansyah Abdin; Siow Ann Chong; Janhavi Ajit Vaingankar; Chao Xu Peh; Lye Yin Poon; Sujatha Rao; Swapna Verma; Mythily Subramaniam
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 7.  Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.

Authors:  Maju Mathews; Srihari Gopal; Isaac Nuamah; Ludger Hargarter; Adam J Savitz; Edward Kim; Wilson Tan; Bernardo Soares; Christoph U Correll
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-21       Impact factor: 2.570

8.  Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic study.

Authors:  Marco Innamorati; Stefano Baratta; Cristina Di Vittorio; David Lester; Paolo Girardi; Maurizio Pompili; Mario Amore
Journal:  Schizophr Res Treatment       Date:  2013-01-21

9.  Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder.

Authors:  H W Moises; D Wollschläger; H Binder
Journal:  Transl Psychiatry       Date:  2015-08-11       Impact factor: 6.222

10.  Gender differences in quality of life and the course of schizophrenia: national study.

Authors:  Anat Rotstein; Efrat Shadmi; David Roe; Marc Gelkopf; Stephen Z Levine
Journal:  BJPsych Open       Date:  2022-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.